AGA Family of Websites:
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
Biosimilars: How to Make the Switch
  April 26, 2021

Watch the second session on biosimilars: How to Make the Switch

Join a multidisciplinary panel of experts, May 5 at 8 p.m. EDT, and learn how to achieve seamless adoption of biosimilars into your practice.
Share on facebook
Share on twitter
Share on linkedin
Share on email

In this second session, multidisciplinary panelists Christina Ha, MD, FACG, AGAF, Maisa Abdalla, MMBS, MPH, Raymond Cross, MD, MS, AGAF, and Heidi Drescher, PA-C, will discuss how to achieve seamless adoption of biosimilars into your practice by building consensus within the multidisciplinary team and including key stakeholders throughout the adoption process. The panel will review:

  • Who takes the lead?
  • One-on-one meetings with each specialty.
  • Identification of issues and concerns.
  • Team meeting to reach consensus.
  • Formulary approval.
  • Trial period.
  • Benefits of adoption of biosimilars.

Watch for the remaining three webinars coming soon:

  • Part three: Integration of the patient perspective through shared decision making and patient counseling. June 23, 8 p.m. EDT
  • Part four: Case studies demonstrating successful transition to a biosimilar. When and when not to switch to a biosimilar. Aug. 25, 8 p.m. EDT.

All sessions will also be available on-demand. If you missed the first session, “What We Know Today About Biosimilars“, you can access it in AGA University.

This four-part series focuses on how to integrate biosimilars into your clinical setting and address any patient concerns about switching therapies. Each activity is free and certified for a maximum of 0.5 AMA PRA Category 1 Credits™, 2.0 total.

This was developed in partnership with Medical Minds and supported by an educational grant from Pfizer, Inc. 

Your hub for GI education is
AGA University
Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.